Celebrates Opening of the Largest Dedicated Cannabis Testing Facility in Canada. VANCOUVER, Oct. 8, 2019 /CNW/ – Anandia Laboratories Inc. (Anandia), announced today the opening of its new headquarters...
Supporting the Growth and Expansion of Anandia’s Independent Cannabis Testing Capabilities EDMONTON, April 25, 2019 /PRNewswire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN:...
This article was published originally at 420 Investor in October A highly disruptive technology that I have discussed over the past few years appears to be gaining traction. Biosynthesis,...
Guest post by Dr. Jon Vaught, CEO and Founder of Front Range Biosciences Starting on October 17, 2018, Canada will have full, country-wide recreational cannabis legalization. As Canada’s licensed producers...
Aurora Cannabis to Acquire Cannabis Science Leader Anandia Laboratories Inc. Boosting IP Portfolio, Cultivar Diversification, Cultivation Efficiencies and Product Development EDMONTON, June 12, 2018 /CNW/ – Aurora Cannabis Inc....
Exclusive Interview with Green Acre Capital Managing Director Matt Shalhoub Private investment firm Green Acre Capital has already deployed over $15 million into private companies in the Canadian cannabis...
Anandia Labs Closes $13.4 Million Private-Placement Financing VANCOUVER, Jan. 16, 2018 /PRNewswire/ – Anandia Laboratories Inc. (“Anandia Labs” or the “Company”), a leading cannabis biotechnology and testing company, is...
Aurora Sets the Standard for Cannabis Industry Product Testing Disclosure VANCOUVER, March 9, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTC: ACBFF) (Frankfurt: 21P;...
In Episode 62 of Investing in Cannabis, Brandon David interviewed Marc Lustig, the CEO of CannaRoyalty (CSE: CRZ) (OTC: CNNRF), a Canadian company that is building a portfolio of...
CannaRoyalty to Acquire 20% of Anandia Labs, a Leader in Cannabis Testing, Extraction and Genetics OTTAWA, ONTARIO–(Marketwired – Jan. 9, 2017) – CannaRoyalty Corp. (CSE: CRZ) (OTC: CNNRF) is...
22nd Century Launches Major New Initiative to Produce Medically-Important Marijuana Cannabinoids 22nd Century is only U.S. firm able to operate freely in the cannabinoid biosynthetic pathway; Company intends to...
In September, the New York Times reported that THC can be produced from yeast. It turns out that not only THC but many of the cannabinoids as well as terpenes...
